Fig. 3. Cumulative incidence of events stratified by IL6 levels.
Events were defined as death from progressive disease or death from toxicity and/or infection after infusion of axi-cel. Patient samples were collected prior to lymphodepleting chemotherapy and stratified by baseline IL6 level ≥ 40pg/mL or <40pg/mL.